+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Circadian Rhythm Sleep Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • September 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5934345
Description Jump to:
The global circadian rhythm sleep treatment market size is likely to be valued at US$ 810 Mn in 2025 and is estimated to reach US$ 1.14 billion by 2032, growing at a CAGR of 5.00% during the forecast period 2025-2032. Growing prevalence of sleep disorders, rising adoption of wearable devices, and increasing awareness about mental health are among the key factors shaping the market outlook.

Market Insights

Circadian rhythm sleep disorders (CRSDs) impact individuals’ ability to maintain normal sleep-wake cycles, leading to fatigue, mood disturbances, and cognitive decline. The treatment market includes a wide spectrum of solutions such as light therapy devices, melatonin-based therapies, pharmacological interventions, and digital health monitoring tools. Increasing demand for non-invasive therapies and technology-driven sleep management solutions is driving growth. Rising awareness about the link between circadian misalignment and chronic diseases such as diabetes and depression is further accelerating adoption across global markets.

Circadian Rhythm Sleep Treatment Market - Report Scope

The circadian rhythm sleep treatment market covers a wide range of therapies and devices aimed at addressing disorders including delayed sleep phase syndrome, advanced sleep phase syndrome, shift work disorder, jet lag, and non-24-hour sleep-wake syndrome. Key solutions involve pharmaceuticals, melatonin analogs, wearable sleep trackers, and smart lighting systems. Consumer preference for convenient, at-home care and increased use of digital tools for sleep monitoring are enhancing product penetration. The market is also benefiting from growing healthcare awareness campaigns and increasing healthcare spending across both developed and emerging regions.

Market Growth Drivers

The market is expanding due to a rising incidence of circadian rhythm sleep disorders driven by irregular work schedules, lifestyle changes, and excessive screen exposure. Growing recognition of the impact of sleep disruption on long-term health outcomes - such as cardiovascular diseases, obesity, and mental health disorders - is boosting demand. Wearables, smart lighting systems, and AI-driven sleep apps are providing accessible and effective treatment options. Additionally, telemedicine adoption and broader public health initiatives are making sleep treatment services more widely available, fueling market expansion.

Market Restraints

The market faces certain challenges, including low awareness levels in developing nations and the high cost of advanced therapeutic devices. Many individuals still rely on unregulated or traditional remedies, limiting adoption of clinical solutions. Pharmacological options may also bring side effects such as dependency, reducing long-term appeal. Lack of standardized treatment protocols and inconsistent regulatory frameworks across regions restrict broader acceptance. Limited reimbursement coverage for sleep-related treatments further hampers accessibility, especially in cost-sensitive markets.

Market Opportunities

Future opportunities in the circadian rhythm sleep treatment market are closely tied to the rise of digital therapeutics and personalized healthcare solutions. AI-powered platforms that customize treatments based on individual sleep patterns are creating new demand. Corporate wellness programs addressing shift work, travel-related jet lag, and employee well-being are emerging as growth avenues. Telehealth services are extending treatment accessibility to underserved regions. Furthermore, targeted therapies for pediatric and elderly populations represent promising new niches, given the higher vulnerability of these groups to sleep-related complications.

Regional Outlook

  • North America leads the global market, supported by advanced healthcare infrastructure, strong consumer awareness, and high adoption of digital health technologies.
  • Europe follows, with growing implementation of light therapy devices and government-backed sleep health initiatives.
  • Asia Pacific is expected to witness the fastest growth, driven by urbanization, rising prevalence of shift work disorders, and rapid digital health adoption.
  • Latin America and Middle East & Africa (MEA) are gradually gaining momentum, with increasing healthcare investments and improving awareness of sleep health benefits.

Leading Companies

Key players in the global circadian rhythm sleep treatment market are actively investing in product innovation, wearable technologies, and strategic collaborations. Companies are expanding their reach through partnerships with healthcare providers and by integrating AI-based monitoring into their solutions.

Major companies covered in the report include:

  • Vanda Pharmaceuticals Inc.
  • Natus Medical Incorporated
  • Compumedics Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company
  • Koninklijke Philips N.V.
  • Mylan N.V.
  • Fitbit, Inc.
  • Garmin Ltd.
  • Lucimed S.A.
  • ResMed Inc.
  • Compass Health Brands (Carex Health)
  • Beurer GmbH
  • Samarit Medical AG
  • Lanaform N.V.

Market Segmentation

By Disorder

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non-24-h Sleep-Wake Syndrome
  • Irregular Sleep-Wake Disorder
  • Shift Work Disorder
  • Jet Lag

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Circadian Rhythm Sleep Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Circadian Rhythm Sleep Treatment Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Treatment Type, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Circadian Rhythm Sleep Treatment Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
5.1. Global Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Device
5.1.1.1.1. Therapeutic Devices
5.1.1.1.1.1. Light Box
5.1.1.1.1.2. Desk Lamps
5.1.1.1.1.3. Light Visor
5.1.1.1.1.4. Dawn Simulator
5.1.1.1.2. Diagnostic Devices
5.1.1.1.2.1. Actigraphy Sensors
5.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
5.1.1.1.2.1.2. Wearable Actigraphy Devices
5.1.1.1.2.2. Polysomnography Devices
5.1.1.1.2.2.1. Fixed Polysomnography Devices
5.1.1.1.2.2.2. Portable Polysomnography Devices
5.1.1.2. Drugs
5.1.1.2.1. Benzodiazepines
5.1.1.2.2. Nonbenzodiazepine hypnotics
5.1.1.2.3. Orexin receptor antagonists
5.1.1.2.4. Melatonin receptor agonist
5.1.1.3. Chronotherapy
5.2. Global Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
5.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
5.2.1.3. Non-24-h Sleep-Wake Syndrome
5.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
5.2.1.5. Shift Work Disorder
5.2.1.6. Jet Lag
5.3. Global Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Institutional Sales
5.3.1.1.1. Home Care Settings
5.3.1.1.2. Wellness Centers & Spa
5.3.1.1.3. Sleep Testing Centers
5.3.1.1.4. Specialty Clinics
5.3.1.1.5. Hospitals
5.3.1.2. Retail Sales
5.3.1.2.1. Retail Pharmacies
5.3.1.2.2. Drug Stores
5.3.1.2.3. Online Sales
5.4. Global Circadian Rhythm Sleep Treatment Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
6.1. North America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Device
6.1.1.1.1. Therapeutic Devices
6.1.1.1.1.1. Light Box
6.1.1.1.1.2. Desk Lamps
6.1.1.1.1.3. Light Visor
6.1.1.1.1.4. Dawn Simulator
6.1.1.1.2. Diagnostic Devices
6.1.1.1.2.1. Actigraphy Sensors
6.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
6.1.1.1.2.1.2. Wearable Actigraphy Devices
6.1.1.1.2.2. Polysomnography Devices
6.1.1.1.2.2.1. Fixed Polysomnography Devices
6.1.1.1.2.2.2. Portable Polysomnography Devices
6.1.1.2. Drugs
6.1.1.2.1. Benzodiazepines
6.1.1.2.2. Nonbenzodiazepine hypnotics
6.1.1.2.3. Orexin receptor antagonists
6.1.1.2.4. Melatonin receptor agonist
6.1.1.3. Chronotherapy
6.2. North America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
6.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
6.2.1.3. Non-24-h Sleep-Wake Syndrome
6.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
6.2.1.5. Shift Work Disorder
6.2.1.6. Jet Lag
6.3. North America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Institutional Sales
6.3.1.1.1. Home Care Settings
6.3.1.1.2. Wellness Centers & Spa
6.3.1.1.3. Sleep Testing Centers
6.3.1.1.4. Specialty Clinics
6.3.1.1.5. Hospitals
6.3.1.2. Retail Sales
6.3.1.2.1. Retail Pharmacies
6.3.1.2.2. Drug Stores
6.3.1.2.3. Online Sales
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. U.S. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.2. U.S. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.3. U.S. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.4. Canada Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.5. Canada Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.1.6. Canada Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
7.1. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Device
7.1.1.1.1. Therapeutic Devices
7.1.1.1.1.1. Light Box
7.1.1.1.1.2. Desk Lamps
7.1.1.1.1.3. Light Visor
7.1.1.1.1.4. Dawn Simulator
7.1.1.1.2. Diagnostic Devices
7.1.1.1.2.1. Actigraphy Sensors
7.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
7.1.1.1.2.1.2. Wearable Actigraphy Devices
7.1.1.1.2.2. Polysomnography Devices
7.1.1.1.2.2.1. Fixed Polysomnography Devices
7.1.1.1.2.2.2. Portable Polysomnography Devices
7.1.1.2. Drugs
7.1.1.2.1. Benzodiazepines
7.1.1.2.2. Nonbenzodiazepine hypnotics
7.1.1.2.3. Orexin receptor antagonists
7.1.1.2.4. Melatonin receptor agonist
7.1.1.3. Chronotherapy
7.2. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
7.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
7.2.1.3. Non-24-h Sleep-Wake Syndrome
7.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
7.2.1.5. Shift Work Disorder
7.2.1.6. Jet Lag
7.3. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Institutional Sales
7.3.1.1.1. Home Care Settings
7.3.1.1.2. Wellness Centers & Spa
7.3.1.1.3. Sleep Testing Centers
7.3.1.1.4. Specialty Clinics
7.3.1.1.5. Hospitals
7.3.1.2. Retail Sales
7.3.1.2.1. Retail Pharmacies
7.3.1.2.2. Drug Stores
7.3.1.2.3. Online Sales
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Germany Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.2. Germany Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.3. Germany Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.4. U.K. Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.5. U.K. Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.6. U.K. Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.7. France Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.8. France Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.9. France Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.10. Italy Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.11. Italy Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.12. Italy Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.13. Turkey Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.14. Turkey Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.15. Turkey Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.16. Russia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.17. Russia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.18. Russia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.19. Rest of Europe Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.20. Rest of Europe Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.1.21. Rest of Europe Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
8.1. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Device
8.1.1.1.1. Therapeutic Devices
8.1.1.1.1.1. Light Box
8.1.1.1.1.2. Desk Lamps
8.1.1.1.1.3. Light Visor
8.1.1.1.1.4. Dawn Simulator
8.1.1.1.2. Diagnostic Devices
8.1.1.1.2.1. Actigraphy Sensors
8.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
8.1.1.1.2.1.2. Wearable Actigraphy Devices
8.1.1.1.2.2. Polysomnography Devices
8.1.1.1.2.2.1. Fixed Polysomnography Devices
8.1.1.1.2.2.2. Portable Polysomnography Devices
8.1.1.2. Drugs
8.1.1.2.1. Benzodiazepines
8.1.1.2.2. Nonbenzodiazepine hypnotics
8.1.1.2.3. Orexin receptor antagonists
8.1.1.2.4. Melatonin receptor agonist
8.1.1.3. Chronotherapy
8.2. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
8.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
8.2.1.3. Non-24-h Sleep-Wake Syndrome
8.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
8.2.1.5. Shift Work Disorder
8.2.1.6. Jet Lag
8.3. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Institutional Sales
8.3.1.1.1. Home Care Settings
8.3.1.1.2. Wellness Centers & Spa
8.3.1.1.3. Sleep Testing Centers
8.3.1.1.4. Specialty Clinics
8.3.1.1.5. Hospitals
8.3.1.2. Retail Sales
8.3.1.2.1. Retail Pharmacies
8.3.1.2.2. Drug Stores
8.3.1.2.3. Online Sales
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. China Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.2. China Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.3. China Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.4. Japan Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.5. Japan Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.6. Japan Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.7. South Korea Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.8. South Korea Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.9. South Korea Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.10. India Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.11. India Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.12. India Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.13. Southeast Asia Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.14. Southeast Asia Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.15. Southeast Asia Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.16. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.17. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.1.18. Rest of Asia Pacific Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
9.1. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. Device
9.1.1.1.1. Therapeutic Devices
9.1.1.1.1.1. Light Box
9.1.1.1.1.2. Desk Lamps
9.1.1.1.1.3. Light Visor
9.1.1.1.1.4. Dawn Simulator
9.1.1.1.2. Diagnostic Devices
9.1.1.1.2.1. Actigraphy Sensors
9.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
9.1.1.1.2.1.2. Wearable Actigraphy Devices
9.1.1.1.2.2. Polysomnography Devices
9.1.1.1.2.2.1. Fixed Polysomnography Devices
9.1.1.1.2.2.2. Portable Polysomnography Devices
9.1.1.2. Drugs
9.1.1.2.1. Benzodiazepines
9.1.1.2.2. Nonbenzodiazepine hypnotics
9.1.1.2.3. Orexin receptor antagonists
9.1.1.2.4. Melatonin receptor agonist
9.1.1.3. Chronotherapy
9.2. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
9.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
9.2.1.3. Non-24-h Sleep-Wake Syndrome
9.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
9.2.1.5. Shift Work Disorder
9.2.1.6. Jet Lag
9.3. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Institutional Sales
9.3.1.1.1. Home Care Settings
9.3.1.1.2. Wellness Centers & Spa
9.3.1.1.3. Sleep Testing Centers
9.3.1.1.4. Specialty Clinics
9.3.1.1.5. Hospitals
9.3.1.2. Retail Sales
9.3.1.2.1. Retail Pharmacies
9.3.1.2.2. Drug Stores
9.3.1.2.3. Online Sales
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Brazil Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.2. Brazil Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.3. Brazil Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.4. Mexico Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.5. Mexico Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.6. Mexico Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.7. Argentina Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.8. Argentina Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.9. Argentina Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.10. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.11. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.1.12. Rest of Latin America Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, 2019-2032
10.1. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. Device
10.1.1.1.1. Therapeutic Devices
10.1.1.1.1.1. Light Box
10.1.1.1.1.2. Desk Lamps
10.1.1.1.1.3. Light Visor
10.1.1.1.1.4. Dawn Simulator
10.1.1.1.2. Diagnostic Devices
10.1.1.1.2.1. Actigraphy Sensors
10.1.1.1.2.1.1. Wrist and Hand band Actigraphy Devices
10.1.1.1.2.1.2. Wearable Actigraphy Devices
10.1.1.1.2.2. Polysomnography Devices
10.1.1.1.2.2.1. Fixed Polysomnography Devices
10.1.1.1.2.2.2. Portable Polysomnography Devices
10.1.1.2. Drugs
10.1.1.2.1. Benzodiazepines
10.1.1.2.2. Nonbenzodiazepine hypnotics
10.1.1.2.3. Orexin receptor antagonists
10.1.1.2.4. Melatonin receptor agonist
10.1.1.3. Chronotherapy
10.2. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Delayed Sleep Phase Syndrome (DSPS)
10.2.1.2. Advanced Sleep Phase Syndrome (ASPS)
10.2.1.3. Non-24-h Sleep-Wake Syndrome
10.2.1.4. Irregular Sleep-Wake Disorder (ISWD)
10.2.1.5. Shift Work Disorder
10.2.1.6. Jet Lag
10.3. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Institutional Sales
10.3.1.1.1. Home Care Settings
10.3.1.1.2. Wellness Centers & Spa
10.3.1.1.3. Sleep Testing Centers
10.3.1.1.4. Specialty Clinics
10.3.1.1.5. Hospitals
10.3.1.2. Retail Sales
10.3.1.2.1. Retail Pharmacies
10.3.1.2.2. Drug Stores
10.3.1.2.3. Online Sales
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Circadian Rhythm Sleep Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. GCC Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.2. GCC Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.3. GCC Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.4. South Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.5. South Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.6. South Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.7. Egypt Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.8. Egypt Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.9. Egypt Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.10. Nigeria Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.11. Nigeria Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.12. Nigeria Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.13. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Treatment Type, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.14. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Disorder, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.1.15. Rest of Middle East & Africa Circadian Rhythm Sleep Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Units), 2019-2032
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By Treatment Type vs by Disorder Heatmap
11.2. Company Market Share Analysis, 2024
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Natus Medical Incorporated
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Compumedics Ltd.
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Teva Pharmaceutical Industries Ltd.
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Takeda Pharmaceutical Company
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Koninklijke Philips N.V
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. Mylan N.V.
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Fitbit, Inc
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Garmin Ltd
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Lucimed S.A.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. RedMed Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Compass Health Brands (Carex Health)
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Beurer GmbH.
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • Vanda Pharmaceuticals Inc.
  • Natus Medical Incorporated
  • Compumedics Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Company
  • Koninklijke Philips N.V
  • Mylan N.V
  • Fitbit, Inc
  • Garmin Ltd
  • Lucimed S.A.
  • RedMed Inc.
  • Compass Health Brands (Carex Health)
  • Beurer GmbH
  • Samarit Medical AG
  • Lanaform N.V.

Related Topics

Related Reports

Sleep Service Providers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Sleep Service Providers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
The Practice of Sleep Medicine Around The World: Challenges, Knowledge Gaps and Unique Needs - Product Image

The Practice of Sleep Medicine Around The World: Challenges, Knowledge Gaps and Unique Needs

  • Book
  • Global
From
Sleeping Aids - A Global Market Overview - Product Image

Sleeping Aids - A Global Market Overview

  • Report
  • 220 Pages
  • Global
From
Melatonin Supplements - Global Strategic Business Report - Product Image

Melatonin Supplements - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Circadian Rhythm Disorders - Pipeline Insight, 2025 - Product Image

Circadian Rhythm Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.